Objective : This retrospective study presents our experience with respect to the clinical and angiographic outcomes of patients treated with stent-assisted coil embolization using Solitaire TM AB stents.
INTRODUCTION
Endovascular management of wide-necked and/or complex intracranial aneurysms has been a therapeutic Here we present our experience with stent-assisted coil embolization of wide-necked and/or complex intracranial aneurysms. We evaluated the efficiency of and morbidity associated with the Solitaire AB stent
and assessed the impact of this technique on angiographic outcomes.
MATERIALS AND METHODS

Patient selection
We investigated retrospectively medical records of Wide-necked aneurysms were defined by a neck width of ≥ 4 mm or a dome-to-neck ratio of < 2.
Almost all cases had wide-necked aneurysms, except one with dissection without aneurysmal dilation. Fifty one aneurysms were small (< 10 mm) and 3 aneurysms were large (≥ 10 mm, 25 mm ≤). No giant (> 25 mm) were observed. 
Endovascular management
In 49 patients, endovascular management was performed through a serial processes as stent was delivered across the aneurysm and deployed to cover its neck and then coils were advanced into the aneurysm sac. A single stenting was performed in one case with dissecting aneurysm. Dual antiplatelet therapy consisted of 100 mg aspirin and 75 mg clopidogrel was administered to patient without SAH every day from 7 days ago before starting procedure. Endovascular procedures were performed under general anesthesia and systemic heparinization. 3,000 IU heparin were administered to patients for achieving an activated clotting time (ACT) between 250 s and 300 s in a bolus intravenously, and 1,000 IU heparin were injected to maintain ACT for each hour thereafter. A unilateral femoral 6-F or 7-F sheath was placed through a percutaneous femoral artery puncture and one 6-F or 7-F guide catheter was inserted into the parent vessel. A Rebar microcatheter was then advanced over a 0.014" microguide wire into the parent artery 1-2 cm beyond the aneurysm. The microcatheter for coiling was navigated into the aneurysmal lumen in order to jail it through deploying the stent. The stent was navigated distally past the aneurysm neck and deployed in the proper position so that each of at least 4 mm from the distal and proximal free margins around the neck to obtain optimal stability. In cases where insufficient alignment occurred, it was technically easy to retrieve and reposition, if necessary, even remove the device before it was detached from the push wire. After achieving the best ideal deployment, the stent was detached from the push wire in all, except two cases with performing temporary stenting. To the next, coiling was performed using bare-platinum coils (Axium, Microplex, Target). In one patient with protruding coil loops of the frame, it was technically feasible to deploy a Solitaire AB stent to push the coil loops into the sac, using the so called "stent-jack technique". 18 1 (27) 1 (14) 1 (49) 1 (11) 1 (12) 1 (12) 1 (19) 2 (36) 2 (24) 2 (28) Unchanged aneurysmal occlusion rate Jailing Bailout Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Jailing Temporary stenting Jailing Jailing Stent-Jack Bailout Jailing Jailing Jailing Jailing
1 (16) 1 (20) 1 (13) 1 (15) 1 (13) 1 (28) 1 (27) 1 (23) 1 (13) 1 (15) 1 (13) 1 (11) 1 (16) 1 (12) 1 (15) 1 (25) 1 (21) Table 1 .
Periprocedural complications
One thromboembolic complication (2%) was encoun- were recanalized, although they didn't necessary to treat again anymore. As a consequence, 67.5% of the aneurysms (n = 27) were found to be completely oc- We performed stent-assisted coil embolization for the two aneurysms one by one in single procedure. First, we performed stent-assisted coil embolization using the jailing technique for the aneurysm of the CMA.
This procedure was successful, resulting in complete occlusion of the aneurysm and procedure-or stent-related complications didn't occur (Fig. 3A) . Subsequently, during coil embolization for the aneurysm at the AcoA, the coil loops protruded to the AcoA and we deployed the Solitaire AB stent from the contralateral A2 to ipsilateral A1 across the AcoA. The flow toward contralateral A2 slowed down and became stagnant.
We confirmed that an in-stent thrombosis was developed ( Fig. 3B ) and ipsilateral A1 was occluded completely (Fig. 3C) . Due to the certain relation between deployment of the device and the complication, as well to prevent an ischemia, the stent was rapidly retrieved in a technically straight-forward manner without complications and Reopro 2 mg was infused in-tra-arterially thereafter. Finally, the occluded vessels were completely recanalized (Fig. 3D) . The Neuroform stent (Boston Scientific, Fremont, CA, USA) was developed as the first self-expandable intracranial stent. This stent has confirmed its superior efficacy and safety in treating wide-necked intracranial aneurysms and also reported lower morbidity and mortality rates associated with the procedure.
3 )14)31)47)51) However, the Neuroform stent has several limitations, such as the inability to reposition it once partially delivered, a low radial force and some deployment difficulties. 14)31) To overcome these limitations, the Leo stent was released as retractable stent for the first time and then the Enterprise stent was developed as an advanced retractable stent. The Enterprise stent is easy to navigate and has been used recently.
28)30)35)
However, these stents have some limitations, such as the need for larger and stiffer delivery catheters and poor visibility, and the development of new devices will be necessary to overcome these disadvantages. First, the coil delivery microcatheter was placed into the aneurysm sac and then the stent was navigated into the parent artery without stent deployment.
12)
The first coil for framing is advanced into the aneurysm lumen, but if coil loops protruded into the parent artery, the stent is then delivered across the aneurysm neck and deployed to go back to protruded coils' original position by pushing coil loops.
The Solitaire AB stent provides the advantage being fully retrievable and redeployable as needed during the procedure until optimal positioning is achieved.
This feature can be used to retrieve the stent at the end of the procedure. Several reports have described temporary stent-assisted coil embolization in patients with ruptured aneurysm using the Solitaire AB stent.
Signorelli et al. 43) and Almekhlafi et al. 2) reported that retrieving the stent after coil embolization reduces the need for continued antiplatelet therapy and decreases the hemorrhagic risks associated with antiplatelet use.
However, stent retrieval is not recommended in situations where a safety margin is not present or is hard to appreciate due to poor visualization of the stent. The authors reported complete occlusion in 42.2% of cases and neck remnant in 39.1%. Additionally, Clajus et al. 7) reported that the complete occlusion rate was 51%, while neck remnants occurred in 44% of cases.
In our series, we obtained a complete occlusion rate of 59% and a neck remnant rate in 24%. Our outcomes were similar to those previously reported for immediate postprocedural occlusions using a Solitaire AB stent.
Stent-assisted coil embolization plays three major roles. First, the stent play a role in supporting the aneurysm neck to fix the coil in the aneurysm sac without protruding inside, and also allows for improved packing density. 
